Open Nav

Universal Sequencing Technology

  • Scott Kozak, Universal Sequencing Technology (UST)

Kick off next round of funding.

  • Date:Thursday, October 18
  • Time:2:45 PM - 3:00 PM
  • Room:Elizabethan B
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:At Universal Sequencing Technology, our solutions will provide technological advancement in the application of DNA sequencing such as genomic and biomedical research, clinical diagnostics of cancer and genetic disease, precision medicine, epidemic prevention, forensic testing, archaeology, and agriculture. Our solutions are easier to use and produce accurate results while providing substantial savings. Tell-Seq enables full-genome sequencing using today's limited sequencing platforms. Our smart barcode technology solves the short sequence reads limitations by enabling 2nd gen sequencers to produce 3rd gen “like” long-read results, which makes the genome assembly easier, more accurate, and further reduces genome sequencing cost by greatly reducing the need for DNA over sampling. A 3rd generation sequencer is our method for nanopore sequencing control. The known technical challenge is control of the movement of DNA through the nanopore. We have solved this issue.
  • Company
  • Company HQ City:Stoughton
  • Company HQ Country:United States
  • Company HQ State:Massachusetts       
  • Main Therapeutic Focus:Tools/Drug Development Support Tech
  • Lead Product in Development :Tell-Seq Long-Read Library Kit
  • Development Phase of Primary Product:Other/Not Applicable
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :2
  • Total Amount Raised to Date, In All Rounds:10 million
Scott Kozak
Universal Sequencing Technology (UST)